Skip to main content
FinSpry Logo
FinSpry
AUPH logo
AUPH
(NASDAQ)
Aurinia Pharmaceuticals Inc.
$16.25-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Aurinia Pharmaceuticals (AUPH) Stock Price & Financial Analysis

Aurinia Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$15.85 - $16.32
52-Week High$19.25
52-Week Low$10.34
Open$15.97
Volume719.08K
Average Volume (3M)1.07M
Market Cap2.24B
Shares Outstanding137.64M
P/E Ratio (TTM)7.50
Forward P/E3.76
Price to Sales (P/S)7.50
Price to Book (P/B)3.94
EV/EBITDA14.18
Revenue (TTM)298.30M
Net Income (TTM)298.21M
Free Cash Flow (TTM)165.55M
EPS (TTM)$2.16
Profit Margin99.97%
Operating Margin41.73%
Return on Equity (ROE)52.54%
Debt to Equity0.12
50-Day MA$15.81
200-Day MA$15.50
52-Week Change31.58%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Aurinia Pharmaceuticals

What is the current stock price for AUPH?

As of the latest trading session, AUPH stock trades at $16.25. The 52-week range is $10.34–$19.25, with a day range of $15.85–$16.32.

What is the P/E ratio for AUPH?

Aurinia Pharmaceuticals's trailing P/E ratio is 7.5, meaning investors pay $7.5 for every $1 of annual earnings. The forward P/E is 3.8, reflecting analyst expectations for future earnings. Aurinia Pharmaceuticals operates in the Healthcare sector.

Does AUPH pay dividends?

Aurinia Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AUPH?

Based on 5 analysts, the consensus for AUPH is Buy.

What is the market cap of AUPH?

Aurinia Pharmaceuticals's market capitalization is $2.24B, classifying it as a mid-cap company. Aurinia Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.